
公司简介
https://www.medtronic.com/contact-us.html
机器人媒体与亮点
精选机器人视频
暂无精选机器人视频
暂无视频
该公司尚未关联精选机器人视频。
机器人概览
相关新闻

Medtronic's Hugo Surgical Robot Clears FDA for General Surgery
The FDA cleared Medtronic's Hugo robotic-assisted surgery system for general surgery procedures including cholecystectomy, hernia repair, gastric bypass, appendectomy and bowel resection, expanding it beyond urology into a caseload worth about 3.5 million U.S. surgeries a year.

Medtronic's Hugo Robot Gets Its First FDA-Cleared Energy Instrument
Medtronic won FDA clearance for the LigaSure RAS Maryland instrument on its Hugo surgical robot, its first robotic vessel-sealing tool, though the US approval still trails what Hugo already supports internationally.

HuaKe Precision Files for STAR Market IPO with Backing from Medtronic
Beijing HuaKe Precision, the company behind the Sinovation SR1 neurosurgical robot, has filed for an IPO on the Shanghai STAR Market to raise about RMB 1 billion. The filing was accepted on June 30, setting the company up to become China's first pure-play neurosurgical robot stock. HuaKe holds a 53.3 percent share of China's neurosurgical robot market, has systems in more than 400 hospitals, and counts global device giant Medtronic as a 3.12 percent shareholder. For hospital buyers and medical device watchers, the prospectus opens a rare window into the real economics of surgical robotics in China.
相关文章

J&J's OTTAVA Breaks Intuitive Surgical's Lock on the OR
Johnson & Johnson's first commercial OTTAVA installation, arriving days after Medtronic's Hugo cleared FDA review, turns surgical robotics from a one-vendor market into a genuine three-way contest with Intuitive Surgical's da Vinci.

The U.S. Is No Longer the First Market a Surgical Robot Conquers
Medtronic's latest Hugo clearance covers one instrument for one U.S. specialty, four years after the platform launched abroad. Across surgical robotics, FDA clearance now proceeds one procedure at a time, and it's made the United States the last major market platforms reach with full capability.

The Surgical Robotics Shakeout: A Bankruptcy, a Duopoly Test, and the Buyer's New Leverage
Surgical robotics just lost one of its most hyped startups to bankruptcy in the same week the premium market gained its first credible second supplier in a generation. This analysis maps the consolidation economics deciding who survives, China's parallel game, and a practical evaluation framework for hospitals entering the duopoly era.
由以下公司打造的机器人 MEDTRONIC
领导层
Geoff Martha (Chairman & CEO)

